[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbImage left, text right\u00bb _builder_version=\u00bb4.16″ custom_padding=\u00bb0|0px|0px|0px|false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2″ use_custom_gutter=\u00bbon\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb padding_top_bottom_link_2=\u00bbtrue\u00bb padding_left_right_link_2=\u00bbfalse\u00bb _builder_version=\u00bb4.16″ width=\u00bb100%\u00bb width_tablet=\u00bb80%\u00bb width_phone=\u00bb80%\u00bb width_last_edited=\u00bbon|tablet\u00bb max_width=\u00bb100%\u00bb max_width_tablet=\u00bb80%\u00bb max_width_phone=\u00bb80%\u00bb max_width_last_edited=\u00bbon|tablet\u00bb module_alignment=\u00bbleft\u00bb min_height=\u00bb677.7px\u00bb custom_margin=\u00bb|auto|-83px|auto|false|\u00bb custom_padding=\u00bb0|12%|0px|0px|false|false\u00bb custom_padding_tablet=\u00bb|0%||\u00bb custom_padding_phone=\u00bb\u00bb module_alignment_tablet=\u00bbcenter\u00bb module_alignment_phone=\u00bbcenter\u00bb module_alignment_last_edited=\u00bbon|tablet\u00bb use_custom_width=\u00bbon\u00bb width_unit=\u00bboff\u00bb custom_width_percent=\u00bb100%\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_image src=\u00bbhttps:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/sebastian-pena-lambarri-Ke8EuI2xOUc-unsplash-scaled.jpg\u00bb alt=\u00bbGreen Rice field in Indonesia\u00bb title_text=\u00bbRice Field Indonesia\u00bb show_bottom_space=\u00bboff\u00bb force_fullwidth=\u00bbon\u00bb align_tablet=\u00bbcenter\u00bb align_phone=\u00bbcenter\u00bb align_last_edited=\u00bbon|desktop\u00bb _builder_version=\u00bb4.16″ background_color_gradient_direction=\u00bb90deg\u00bb background_color_gradient_start=\u00bb#404451″ background_color_gradient_end=\u00bbrgba(240,242,246,0)\u00bb custom_padding=\u00bb||||false|false\u00bb custom_padding_tablet=\u00bb||60px|\u00bb custom_padding_phone=\u00bb||10px||false|false\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbleft\u00bb animation_intensity_slide=\u00bb1%\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb13px\u00bb custom_padding=\u00bb|||60px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n
Featured image: Photo by Sebastian Pena Lambarri<\/a> on Unsplash<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ custom_padding=\u00bb6vw||6vw|\u00bb custom_padding_tablet=\u00bb0px|0px|0px|0px|false|true\u00bb custom_padding_phone=\u00bb||||false|false\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb padding_phone=\u00bb||||false|false\u00bb padding_tablet=\u00bb|10%||10%|false|true\u00bb padding_last_edited=\u00bbon|tablet\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ text_font=\u00bb||||||||\u00bb header_font=\u00bb||||||||\u00bb header_3_text_color=\u00bb#3550a0″ header_6_font=\u00bb||||||||\u00bb max_width=\u00bb942px\u00bb custom_margin=\u00bb-60px|||||\u00bb custom_padding=\u00bb0px|0px||0px||\u00bb header_3_font_size_tablet=\u00bb\u00bb header_3_font_size_phone=\u00bb20px\u00bb header_3_font_size_last_edited=\u00bbon|desktop\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n All indicators are green for the Indonesian Self-Medication and Prescription Drugs market. Continue reading to find out about the opportunities this market has to offer.\u00a0<\/span><\/i><\/p>\n Indonesia is the <\/span>fourth most populous<\/b> country in the world with 277 mio. inhabitants, and its gross domestic product (GDP) has been growing in recent years. Three percent of Indonesia\u2019s GDP is spent on healthcare, and pharmaceutical spending per capita is increasing rapidly. Indonesia has almost ten thousand primary care centers and more than two thousand hospitals. <\/span>The Indonesian OTC & Pharma is expanding rapidly and should reach USD 18,409 Billion ex-factory in <\/b>2040<\/b>.<\/b><\/p>\n In order to register a drug in Indonesia, applications go to the<\/span> National Agency of Drug and Food Control (NADFC)<\/b>. The Association of Southeast Asian Nations (ASEAN) Common Technical Documents (CTD) must be used, and ASEAN standards should be followed. It can take up to <\/span>2-3 years<\/b> for a pharmaceutical product to be registered in Indonesia, but the government implemented new regulations in 2016 to simplify the process in the next few years.\u00a0<\/span><\/p>\n Over the last few years, the government of Indonesia has passed laws to <\/span>improve its healthcare infrastructure and increase public spending on healthcare. <\/b>At the beginning of 2014, Indonesia introduced a universal healthcare system, administered by the National Social Security Agency. The universal healthcare scheme aims to provide better regulations, access, cost effectiveness and standards. 86%<\/span> of the population was enrolled into the NHI scheme by the beginning of 2022<\/b>.\u00a0<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb0px|||||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bb#001389″ global_colors_info=\u00bb{}\u00bb]<\/p>\n The main obstacles to big investments in Indonesia\u2019s OTC and pharma industry are corruption, low cost per capita for health care services and a relatively small percentage of elderly residents. However, this percentage is rising and the very large young population represents a significant target consumer base for children\u2019s products.<\/span><\/p>\n Several Indonesian laws protect the local industry from foreign competition. One of the decrees adopted in 2008 requires that all pharmaceuticals registered in the country be <\/span>locally produced<\/b>. This law was <\/span>eased in 2010<\/b>, allowing labeling and packaging to meet the local manufacturing standard. Foreign OTC and pharma companies have reacted to this decree by partnering with domestic companies or other international companies, or by expanding their own local manufacturing capacities in Indonesia.<\/span><\/p>\n As a part of measures for increasing the capacity of the national Consumer Health and Pharma market, the Pharmaceutical Association of Indonesia (GP Farmasi) announced that the domestic Healthcare sector relies on the creation of factories owned by foreign companies within the country. At the same time, active cooperation with OTC and Pharma companies of the Association of Southeast Asian Nations (ASEAN) is assumed. The <\/span>goal <\/b>is to create an <\/span>industrial base of pharmaceutical raw materials in Indonesia<\/b>. The data collected by GP Farmasi shows that the market for Selfmedication and Pharma products in the ASEAN region is rising.<\/span><\/p>\n At the same time, the National AIDS Commission has said that to ensure a steady supply of antiretroviral drugs to patients with AIDS, Indonesia will continue to receive donations in the form of drugs rather than cash. This new rule was approved by the <\/span>Global Fund for AIDS<\/b>, <\/span>Tuberculosis <\/b>and <\/span>Malaria<\/b>. The Indonesian Ministry of Health has also allocated money to develop solutions and treatments against AIDS.\u00a0<\/span><\/p>\n However, despite the above-mentioned challenges, the Indonesian consumer health and pharma market still provides a significant <\/span>opportunity for foreign self-medication and prescription companies<\/b>. Factors such as the annual growth of the Indonesian pharma market, along with the increase in population and relatively solid economic and political base, should ensure the continued involvement of multinational pharmaceutical companies. Analysts believe that sales of pharmaceutical products in Indonesia will continue to increase over the next 10 years.<\/span><\/p>\n \u00a0<\/span><\/p>\n If you are planning on entering the Indonesian OTC and pharma market, our expertise and long standing network can support you. Chameleon Pharma Consulting Group\u2019s knowledge of the Indonesian consumer healthcare and pharma market is based on multiple Indonesian projects over the past 15 years. All our experts have at least 20 years experience, and we have supported several leading European and international companies in entering the Health care, Medical devices and prescription sectors of Indonesia.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbExpert Knowledge\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb609.2px\u00bb custom_margin=\u00bb-67px||-121px|||\u00bb custom_padding=\u00bb69px|||||\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbRow\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb45px\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_icon font_icon=\u00bb||divi||400″ icon_color=\u00bb#001389″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_icon][et_pb_text _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n OTC and pharma market size, ex-factory<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_icon font_icon=\u00bb||divi||400″ icon_color=\u00bb#001389″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_icon][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n OTC and pharma market growth<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbNumber Counter\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#EEEEEE\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbTotal population\u00bb number=\u00bb 275 122 131″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb number_font_size=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbMale\/Female\u00bb number=\u00bb1″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbPopulation growth\u00bb number=\u00bb0.81%\u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbBirth rate\u00bb number=\u00bb15.58\/1000″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb number_font_size=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbMortality rate\u00bb number=\u00bb6.74\/1000″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbLife expectancy\u00bb number=\u00bb72.82 years\u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_cta title=\u00bbInterested in this market?\u00bb button_url=\u00bbhttps:\/\/www.chameleon-pharma.com\/about\/contacts\/\u00bb button_text=\u00bbClick here\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n <\/span><\/p>\n We are ready to support you in\u00a0<\/span>Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory\u00a0projects,<\/span>\u00a0and more in order to ensure your growth.<\/span><\/p>\n<\/div>\n<\/div>\n [\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Indonesia\u00a0Featured image: Photo by Sebastian Pena Lambarri on UnsplashIndonesia: a Self-Medication and Prescription Drugs market full of opportunities\u00a0 All indicators are green for the Indonesian Self-Medication and Prescription Drugs market. Continue reading to find out about the opportunities this market has to offer.\u00a0 Indonesia is the fourth most populous country in the world with 277 […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":39,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_873\" align=\"alignleft\" width=\"300\"]Indonesia: a Self-Medication and Prescription Drugs market full of opportunities\u00a0<\/strong><\/h2>\n
Product Registration in Indonesia<\/b><\/h3>\n
Improving healthcare<\/b><\/h3>\n
Regulations and restrictions in Indonesia<\/b><\/h3>\n
Increasing the Indonesian National Consumer Health and Pharma market<\/b><\/h3>\n
Drug donations to fight AIDS<\/b><\/h3>\n
Future Outlook<\/b><\/h3>\n
The Indonesian OTC and pharma market in 2040<\/h2>\n
USD 18,40 Billion <\/b><\/h3>\n
7-9<\/b>%<\/b><\/h3>\n
Indonesia in numbers<\/h2>\n
![\"Indonesia](\"https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/2014\/07\/Indonesia-TRIUMPH.jpg\")
Indonesia<\/a> by F Mira<\/a> with CC<\/a>[\/caption]\r\n\r\nWith a pop\u00adu\u00adla\u00adtion of 237 mil\u00adlion peo\u00adple, Indone\u00adsia is the fourth most pop\u00adu\u00adlated coun\u00adtry in the world<\/strong>. Within the Pharma mar\u00adket, it boasts a total annual growth of 13%, and the demand for qual\u00adity health\u00adcare prod\u00aducts is very high. From 2008 to 2013, Indonesia\u2019s expen\u00addi\u00adtures in the health\u00adcare sector increased from US $12.65 bil\u00adlion to approx\u00adi\u00admately US $26.93 bil\u00adlion.\r\n\r\nCon\u00adtrary to fore\u00adcasts made by numer\u00adous spe\u00adcial\u00adists, the lead\u00ading index IDX has tripled since 2009. The Indone\u00adsian pop\u00adu\u00adla\u00adtion is young, national debts are low, and the gov\u00adern\u00adment is ready to increase the flow of money within the health\u00adcare sec\u00adtor. The population\u2019s currently low con\u00adsump\u00adtion of Pharma prod\u00aducts coupled with its growing readi\u00adness to invest in health\u00adcare prod\u00aducts create an excellent potential for growth; the Indonesian Pharma mar\u00adket could eas\u00adily reach approx\u00adi\u00admately US $11.8 bil\u00adlion by 2015. Fur\u00adther\u00admore, the Indone\u00adsian gov\u00adern\u00adment is will\u00ading to favour part\u00adner\u00adships with for\u00adeign Pharma com\u00adpa\u00adnies, since the domes\u00adtic devel\u00adop\u00adment of health\u00adcare prod\u00aducts is still at a very low stan\u00addard.\r\n\r\n\r\n\r\n\r\n\r\n\r\nCPC Press Releases on Indonesia:<\/strong><\/h3>\r\nIndonesia: A lucrative market<\/a><\/strong>","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8794","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/comments?post=8794"}],"version-history":[{"count":15,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8794\/revisions"}],"predecessor-version":[{"id":22253,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8794\/revisions\/22253"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/media?parent=8794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}